Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081393 | SCV000563616 | likely benign | Charcot-Marie-Tooth disease type 2E | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000507003 | SCV000604449 | benign | not specified | 2018-10-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000057142 | SCV000714728 | likely benign | not provided | 2019-05-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16930284, 20039262, 17052987, 32376792) |
Ce |
RCV000057142 | SCV000892829 | uncertain significance | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001160882 | SCV001322718 | benign | Charcot-Marie-Tooth disease type 1F | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Molecular Genetics Laboratory, |
RCV001173051 | SCV001336126 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002362689 | SCV002658837 | uncertain significance | Inborn genetic diseases | 2023-12-19 | criteria provided, single submitter | clinical testing | Unlikely to be causative of autosomal dominant NEFL-related Charcot-Marie-Tooth disease Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Epithelial Biology; Institute of Medical Biology, |
RCV000057142 | SCV000088255 | not provided | not provided | no assertion provided | not provided | ||
Inherited Neuropathy Consortium | RCV000507003 | SCV000928962 | uncertain significance | not specified | no assertion criteria provided | literature only | ||
Clinical Genetics, |
RCV000507003 | SCV001919054 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000057142 | SCV001969688 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925018 | SCV004738130 | likely benign | NEFL-related disorder | 2021-04-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |